Cancer Clinical Trials & Investigational Medicine Units
Connecting Singapore's leading cancer centres, clinicians and industry partners to accelerate innovative cancer clinical trials, enabling faster access to novel therapies
Clinical trials are essential to advancing cancer care. STCC accelerates the delivery of innovative oncology studies by providing end-to-end support across feasibility assessments, study start-up, regulatory approvals, contracting, project management and multi-site coordination.
By bringing together leading cancer centres, clinicians and industry partners, STCC streamlines trial execution, expands patient access to novel therapies, and fosters a collaborative research ecosystem that accelerates the translation of scientific discoveries into better treatments and outcomes for patients across Singapore.
Simplifying Multi-Centre Cancer Trials in Singapore
Multi-Centre Collaborative Framework
An established framework for collaborative multi-centre cancer research with streamlined contracting and centralised workflows to facilitate multi-centre studies.
Translational Cancer Research Collaborations
Active coordination and promotion of translational cancer research collaborations across and amongst the various Large Collaborative Grant (LCG) programmes and cancer groups.
National KOL Tumour Groups
A national Key Opinion Leader (KOL) group, the STCC Tumour Groups, comprising multidisciplinary experts from all three healthcare clusters in Singapore. The group works to develop a strategic cancer research agenda aligned with national needs, shape Singapore's cancer research ecosystem through high-priority trials with strong translational value, and drive regional clinical trial collaborations for the conduct of cross-border studies.
Browse cancer clinical trials (opens in new tab) that are currently recruiting participants through Singapore's National Clinical Trials Portal (CTSG). To find relevant studies, select "Cancer" under the Therapeutic Area filter.
Our KOLs
Solid Tumours
Breast Cancers
Thoracic, Head and Neck Cancers
Gastrointestinal (GI) Cancers
Genito-urinary (GU) Cancers
Sarcoma and Rare Malignancies (including central nervous system cancers)
Haematologic Malignancies
Lymphoma
Leukemia
Early Phase and Clinical Pharmacology
Phase 1 and Clinical Pharmacology
Nucleic Acid Therapeutics and Cancer Vaccines
Why Collaborate With STCC
Single access to Singapore's major oncology institutions and investigators through a coordinated multi-centre trial network.
Faster study activation through centralized coordination of site engagement, regulatory processes, contracting, and study start-up activities.
Access to diverse Asian patient populations and tumour profiles to support regional drug development and precision oncology strategies.
Ready to collaborate or conduct a trial in Singapore?
Connect with leading cancer centres, clinician-investigators and research expertise through a single point of access for multi-centre clinical trials, from feasibility to study delivery.